
Unlock the Future of Medicine: Prepaire’s Universal App Store Your Gateway to Disease Modeling, Drug Discovery, Regenerative Therapies, and Beyond
Employees: 51-200
Mentions in press and media 10
Date | Title | Description |
30.01.2025 | American Hospital Dubai enters new collaboration to make Medicine 3.0 and increased health-span a reality | Launch at Arab Health 2025 The hospital introduces the region's first GenetiQ Digital Twin platform, ushering in a new era in predictive and preventive healthcare. DUBAI, DUBAI, UNITED ARAB EMIRATES, January 30, 2025 /EINPresswire.com/ -- A... |
05.02.2024 | Prepaire Labs Strengthens Genomic Sequencing Capabilities through Strategic Collaboration with MGI | T20 Medlab Dubai Advancing Personalized Medicine: Prepaire Labs and MGI Join Forces to Enhance Genomic Sequencing and Drug Discovery MASDAR CITY, ABU DHABI, UNITED ARAB EMIRATES, February 5, 2024 /EINPresswire.com/ -- In a significant strid... |
04.02.2024 | Prepaire Labs Commits to Carbon Neutrality | Prepaire Labs HQ On the occasion of National Environment Day the Company is Announcing its commitment to protect and preserve the environment. MASDAR CITY, ABU DHABI, UNITED ARAB EMIRATES, February 4, 2024 /EINPresswire.com/ -- Prepaire Lab... |
19.01.2024 | Chemify and Prepaire Labs Collaborate to Revolutionize Opioid Discovery With AI-Driven Robotics | Chemify and Prepaire Labs announced to expand their partnership with an additional program to tackle the ongoing Opioid crisis and develop a novel class of digitally discovered non-addictive Opioids as pain modulators, as well as drugs tack... |
22.06.2023 | PREPAiRE Accelerates Discovery Leveraging CAS SciFinder Discovery Platform | Collaboration will provide access to the most authoritative scientific information available from CAS. DUBAI, UNITED ARAB EMIRATES, June 22, 2023/EINPresswire.com/ -- Prepaire Labs, an innovator in AI-driven drug discovery are pleased to an... |
12.06.2023 | Prepaire Labs™ Receives Two Patents for New Anti-Viral Drug | The new combination molecule, Cydlavim™ was developed in record time using the Prepaire Operating-System DUBAI, UNITED ARAB EMIRATES, June 12, 2023/EINPresswire.com/ -- Prepaire Labs, an innovator in AI-driven drug discovery, is proud to an... |
05.06.2023 | Prepaire Labs Acquires State-of-the-Art 3D Bioprinter from CELLINK for New UAE Research Lab | Generation 3 of the most advanced bioprinter enabling high-throughput 3D cell culturing and biofabrication to create the future of health. Furthers steps to build a High Throughput Lab in the United Arab Emirates DUBAI, UNITED ARAB EMIRATES... |
23.05.2023 | Prepaire Labs Enters Negotiations with European Investment Firm in $30 Million Deal | DUBAI, UNITED ARAB EMIRATES, May 23, 2023/EINPresswire.com/ -- Prepaire Labs, a pioneering biotechnology company revolutionizing drug discovery and precision medicine, has entered into advanced negotiations with a European investment firm r... |
21.11.2022 | Prepaire™ Announces Partnership With Ncardia To Accelerate Plans To Discover New Drugs & Repurpose Existing Libraries | Ncardia to develop and manufacture Induced Pluripotent Stem-Cell based solutions (iPSC) for Prepaire. DUBAI, UNITED ARAB EMIRATES, November 21, 2022 /EINPresswire.com/ -- Prepaire™ Labs, an Omics company, mining, mapping & navigating bi... |
19.09.2022 | Prepaire Launches Shield™, A Dedicated Drug Discovery Platform To Find Therapies & Antidotes Against Chemical Agents | DUBLIN, IRELAND , September 19, 2022 /EINPresswire.com/ -- Prepaire, a commercial-stage omics company leveraging the power of AI to revolutionize drug discovery, today announces the launch of a dedicated platform called Prepaire Shield. In ... |